Suheung Capsul - Asset Resilience Ratio

Latest as of December 2025: 0.99%

Suheung Capsul (008490) has an Asset Resilience Ratio of 0.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 008490 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩10.52 Billion
≈ $7.13 Million USD Cash + Short-term Investments

Total Assets

₩1.06 Trillion
≈ $719.12 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Suheung Capsul's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Suheung Capsul.

Liquid Assets Composition Over Time

This chart breaks down Suheung Capsul's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Suheung Capsul to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩10.52 Billion 0.99%
Total Liquid Assets ₩10.52 Billion 0.99%

Asset Resilience Insights

  • Limited Liquidity: Suheung Capsul maintains only 0.99% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Suheung Capsul Industry Peers by Asset Resilience Ratio

Compare Suheung Capsul's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for Suheung Capsul (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Suheung Capsul.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.99% ₩10.52 Billion
≈ $7.13 Million
₩1.06 Trillion
≈ $719.12 Million
-0.11pp
2024-12-31 1.10% ₩11.22 Billion
≈ $7.60 Million
₩1.02 Trillion
≈ $689.68 Million
+0.12pp
2023-12-31 0.98% ₩9.71 Billion
≈ $6.58 Million
₩993.74 Billion
≈ $673.44 Million
-1.32pp
2022-12-31 2.30% ₩21.30 Billion
≈ $14.43 Million
₩926.42 Billion
≈ $627.82 Million
+1.33pp
2021-12-31 0.97% ₩7.85 Billion
≈ $5.32 Million
₩809.95 Billion
≈ $548.89 Million
-1.47pp
2020-12-31 2.44% ₩18.68 Billion
≈ $12.66 Million
₩765.99 Billion
≈ $519.10 Million
+1.29pp
2019-12-31 1.15% ₩8.14 Billion
≈ $5.51 Million
₩708.86 Billion
≈ $480.39 Million
+0.87pp
2018-12-31 0.28% ₩1.78 Billion
≈ $1.21 Million
₩639.10 Billion
≈ $433.11 Million
+0.03pp
2017-12-31 0.25% ₩1.49 Billion
≈ $1.01 Million
₩595.29 Billion
≈ $403.42 Million
-0.68pp
2016-12-31 0.93% ₩5.43 Billion
≈ $3.68 Million
₩585.89 Billion
≈ $397.05 Million
+0.20pp
2015-12-31 0.73% ₩4.05 Billion
≈ $2.74 Million
₩556.75 Billion
≈ $377.30 Million
-0.01pp
2014-12-31 0.73% ₩3.60 Billion
≈ $2.44 Million
₩491.21 Billion
≈ $332.88 Million
-0.06pp
2013-12-31 0.79% ₩3.69 Billion
≈ $2.50 Million
₩466.55 Billion
≈ $316.17 Million
+0.45pp
2012-12-31 0.34% ₩1.60 Billion
≈ $1.08 Million
₩466.47 Billion
≈ $316.12 Million
+0.31pp
2011-12-31 0.03% ₩138.40 Million
≈ $93.79K
₩434.23 Billion
≈ $294.27 Million
-0.08pp
2010-12-31 0.11% ₩410.00 Million
≈ $277.85K
₩359.76 Billion
≈ $243.80 Million
-1.94pp
2009-12-31 2.05% ₩5.23 Billion
≈ $3.54 Million
₩255.24 Billion
≈ $172.97 Million
-5.26pp
2008-12-31 7.31% ₩18.75 Billion
≈ $12.71 Million
₩256.71 Billion
≈ $173.97 Million
-9.87pp
2007-12-31 17.18% ₩33.02 Billion
≈ $22.38 Million
₩192.26 Billion
≈ $130.29 Million
+7.19pp
2006-12-31 9.99% ₩16.42 Billion
≈ $11.13 Million
₩164.35 Billion
≈ $111.38 Million
-3.29pp
2005-12-31 13.28% ₩21.00 Billion
≈ $14.23 Million
₩158.14 Billion
≈ $107.17 Million
+13.18pp
2003-12-31 0.10% ₩105.34 Million
≈ $71.39K
₩110.72 Billion
≈ $75.03 Million
-4.18pp
2002-12-31 4.27% ₩4.88 Billion
≈ $3.31 Million
₩114.22 Billion
≈ $77.41 Million
+0.99pp
2001-12-31 3.29% ₩4.01 Billion
≈ $2.72 Million
₩122.19 Billion
≈ $82.81 Million
-9.78pp
2000-12-31 13.06% ₩17.12 Billion
≈ $11.60 Million
₩131.06 Billion
≈ $88.81 Million
--
pp = percentage points

About Suheung Capsul

KO:008490 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$152.97 Million
₩225.72 Billion KRW
Market Cap Rank
#17675 Global
#732 in Korea
Share Price
₩20300.00
Change (1 day)
+1.50%
52-Week Range
₩16200.00 - ₩30200.00
All Time High
₩57799.21
About

Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver… Read more